EI
MRTX

Ellevest Inc’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Ellevest Inc’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21
Closed -$1K – 1933
2022
Q2 		$1K Buy
+21
New +$1.34K ﹤0.01% 1352
2021
Q4 		– Sell
-16
Closed -$3K – 1710
2021
Q3 		$3K Buy
+16
New +$2.57K ﹤0.01% 1090
2021
Q1 		– Sell
-7
Closed -$2K – 1380
2020
Q4 		$2K Buy
+7
New +$1.51K ﹤0.01% 1009

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Ellevest Inc's MRTX Position: Q3 2022 in Review

Ellevest Inc sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2022, closing a stake of 21 shares — an estimated $1K sold.

Ellevest Inc first reported a position in MRTX in Q4 2020 and held it in 3 quarters. The position peaked at $3K in Q3 2021. 243 funds tracked by Wall St. Rank hold MRTX as of Q3 2022.

  • Ellevest Inc reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ellevest Inc sold 21 Mirati Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • Ellevest Inc first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Ellevest Inc's Mirati Therapeutics, Inc. Common Stock position peaked at $3K in Q3 2021.
  • 243 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Ellevest Inc's 13F filing for Q3 2022, filed 2 Nov 2022.